Navigation Links
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Date:12/11/2007

a nephrotoxic agent. ATRIPLA may cause fetal harm when administered during the first trimester to a pregnant woman. Women should not become pregnant or breast-feed while taking ATRIPLA. Barrier contraception must always be used in combination with other methods of contraception (eg, oral or other hormonal contraceptives). If the patient becomes pregnant while taking ATRIPLA, she should be apprised of the potential harm to the fetus.

Mild-to-moderate rash is a common side effect of efavirenz. In controlled clinical trials, 26% of patients treated with efavirenz experienced new-onset skin rash compared with 17% of patients treated in control groups. ATRIPLA should be discontinued in patients developing severe rash associated with blistering, desquamation, mucosal involvement, or fever. Skin discoloration, associated with emtricitabine, may also occur.

Liver enzymes should be monitored in patients with known or suspected hepatitis B or C and when ATRIPLA is administered with ritonavir or other medications associated with liver toxicity.

Decreases in bone mineral density (BMD) have been seen with tenofovir DF. Cases of osteomalacia (associated with proximal renal tubulopathy) have been reported in association with the use of tenofovir DF.

Use ATRIPLA with caution in patients with a history of seizures. Convulsions have been observed in patients receiving efavirenz, generally in the presence of known medical history of seizures.

Redistribution/accumulation of body fat has been observed in patients receiving antiretroviral therapy.

Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including the components of ATRIPLA.

Saquinavir should not be used as the only protease inhibitor in combination with ATRIPLA.

Coadministration of ATRIPLA and atazanavir is not recommended due to concerns regarding decreased atazanavir concentrations. Atazanavir and lopinavir/rito
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
3. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 Today ... joins over 150 major food companies, retailers, and ... House Forum on Antibiotic Stewardship. CSTE is committed ... antibiotic-resistant bacteria, detect resistant strains, preserve the efficacy ... of resistant infections. CSTE continues to ...
(Date:6/2/2015)... , June 2, 2015  ErgoNurse, the leader in bedside ... healthcare products in the United States , ... home, long-term care and skilled nursing markets. ... Thousands ... to fully take advantage of the ErgoNurse products to stop ...
(Date:6/2/2015)... CAMBRIDGE, Mass. , June 2, 2015 /PRNewswire/ ... has expanded its offerings with the addition of ... ARISg™, a world leader in safety data collection ... safety and regulatory affairs professionals, and expert physicians, ... industry, provide clinical interpretation and monitoring of safety ...
Breaking Medicine Technology:ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2PROMETRIKA Announces the Availability of Pharmacovigilance Services 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 ZOOM+, the ... ZOOM+ Performance Health Insurance, announced today the opening of ... White 57 - a three-in-one complete dental exam, cleaning ... Jr. for kids. Like all ZOOM+ services, ZOOM+Smile can ... “Why shouldn’t the dentist office be as inviting as ...
(Date:6/2/2015)... CITY, Mo. (PRWEB) June 02, 2015 With ... Tutera Senior Living & Health Care has hired Leslie ... Tutera’s expansion of human resource initiatives to better understand and ... and families in Tutera’s 47 communities in 13 states across ... the highest levels of personalized support to our residents, we ...
(Date:6/2/2015)... Cochrane, Alberta (PRWEB) June 02, 2015 ... (ULP) wireless technology, highlights North Pole Engineering’s (NPE) ... utilizing ANT Wireless technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. ... and ANT-FS) and Bluetooth Smart® bridge solution that ... be transmitted over WiFi or Ethernet networks. ...
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... 02, 2015 Vancouver, BC – ... Research ( http://www.idataresearch.com ), the bone graft substitute ... matrices (DBM) over traditional allograft materials. Because the ... thus an increase in operation time, alternative graft ... growth in these synthetic materials is partly the ...
Breaking Medicine News(10 mins):Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3
... bought from doctors checked their prescriptions, kept exam dates, study ... buying contact lenses online may save time in the short-term, ... care, new research shows. , Time saved with ... line, warned the investigators, who found that people purchasing lenses ...
... ARBOR, Mich. Medical breakthroughs in recent decades have ... live longer. But as their hearts decline into congestive ... the need for nursing-home care. , A new study ... VA Ann Arbor Healthcare System sheds light on the ...
... Experts are warning policy makers that allergic disease might ... health in cities undergoing rapid demographic changes in developing ... of childhood eczema across the globe has revealed big ... last five to ten years and suggests that environmental ...
... effect on weight at age 2, study says , , MONDAY, Jan. ... trying to get them to eat less or to ... of 2, new British research suggests. , While a lower weight ... interest of a young child, according to the report in the ...
... Jan. 7 Immucor, Inc. (Nasdaq:,BLUD), a global ... transfusion industry, today announced an update to the ... call to be held on,Tuesday, January 8, 2008 ... telephone,conference call, dial 1-888-950-8044 and passcode BLUD., ...
... Parkway Clinical Laboratories, (http://www.parkwayclinical.com ), a national, ... has expanded its,management team by naming Mats Sanden, ... president of Operations, Carolyn Bonner as director,of Business ... "We begin the New Year with a ...
Cached Medicine News:Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2Health News:Congestive heart failure leads to greater disability, nursing home admissions 2Health News:Eczema still on the increase in developing countries 2Health News:Eczema still on the increase in developing countries 3Health News:Parental Control of Eating Leads to Lighter Toddlers 2Health News:Parental Control of Eating Leads to Lighter Toddlers 3Health News:Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening 2
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: